DAY 2 SESSION 2: THE ADVANCEMENT OF INDIA AS A HUB OF DIAGNOSTIC SOLUTIONS

πˆππƒπˆπ€’𝐒 π‘πˆπ’π„ 𝐀𝐒 𝐀 πƒπˆπ€π†ππŽπ’π“πˆπ‚π’ 𝐒𝐔𝐏𝐄𝐑𝐇𝐔𝐁

Leading minds launched into a stirring exchange of views and visions as they traced the evolution of India’s diagnostics sector as a force to reckon with globally. 

We express our heartfelt gratitude to everyone for elevating Day 2 at π•πŽπ‡ πƒπˆπ†πˆπ“π€π‹ 𝐇𝐄𝐀𝐋𝐓𝐇𝐂𝐀𝐑𝐄 π‚πŽππ…π„π‘π„ππ‚π„ 𝟐𝟎𝟐𝟐 (πŸ”π­π‘ 𝐄𝐝) with substance and inspiration.

ππˆπ† π“π‡π€ππŠπ’ π“πŽ

Dr. Sanjay Arora, Founder & Chairman, Suburban Diagnostics India, Group Medical Director, Dr Lal PathLabs 

Pallavi Jain, Managing Director, Krsnaa Diagnostics Ltd. (Formerly known as Krsnaa Diagnostics Pvt. Ltd.)

Narendra Varde, Managing Director, Roche Diagnostics India, Neighbouring Markets

Sridhar Natarajan, Managing Director SWA (India and Neighboring markets), Beckman Coulter Diagnostics, Danaher Corporation

Puneet Gupta, Chief Operating Officer, Redcliffe Labs

Mukund Malani, Co-founder, CrelioHealth (formerly LiveHealth)

Koustav Chatterjee, Head - Digital Health Ecosystem, NASSCOM

By: Koustav Chatterjee - 21-May 2022

BROADCAST

Partners & Associates